HawkCell Revolutionizes Veterinary Care with Innovative MRI Technology
March 17, 2024, 2:21 pm
HawkCell, a Lyon-based veterinary care and preclinical research company, has secured €5M in Series A funding to scale up its business and expand into the North American pet market. Led by CEO Alexis Girin, HawkCell specializes in healthtech innovation with its magnetic resonance imaging (MRI) technology, offering rapid, accurate, and quantitative analyses for veterinarians and researchers. The company's unique system incorporates hardware and software solutions, including 3D-printed MRI coils and AI algorithms, to provide high-quality imaging for animals. With the support of MIG Capital and a French investment bank, HawkCell aims to bridge the gap between human and veterinary medicine, revolutionizing the future of animal imaging and care.